As the transition from fee-for-service to value-based care continues to disrupt the healthcare industry, payers and providers must share data with each other—and increase transparency—to drive costs down. That was among the messages Verscend president and CEO Dr. Emad Rizk recently shared with the Red Hot Healthcare podcast, which features in-depth interviews with top leaders in the healthcare analytics industry.
Stream or download the podcast below to hear Dr. Rizk discuss:
How and why population health management has replaced disease management
What the concept of “strength from all sides” means
How the 20-year legacy of DxCG Intelligence changed the healthcare industry
How data sharing and automation reduce healthcare costs and improve outcomes
What the future is for Verscend’s “Best in KLAS” quality analytics and reporting solution
Interested in learning more about Verscend’s DxCG risk adjustment and predictive models, as Dr. Rizk discussed in the podcast? Download our white paper for a look at their evolution.
Dr. Emad Rizk joined Verscend in August 2016 and serves as president and CEO. A seasoned and renowned healthcare industry senior executive, Dr. Rizk brings to this role more than 25 years of experience working closely with payers, providers, and government entities. Most recently, he served as CEO of Accretive Health and was also a member of its board of directors. Prior to Accretive Health, Dr. Rizk was president of McKesson Health Solutions, a business that provides clinical and financial solutions to healthcare payers.
Dr. Rizk’s work has been published frequently in journals and books, and he has been widely recognized in the healthcare Industry. Modern Healthcare has named Dr. Rizk numerous times as one of the “50 Most Influential Physician Executives in the United States,” and the “Top 100 Most Powerful People in Healthcare.” Managed Healthcare Executive also named him to its “Top 25 Leaders in Disease Management.”